Dreman Value Management’s Eli Lilly LLY Stock Holding History

Dreman Value Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-900	Closed	-$72K	–	470
2016 Q3	$72K	Hold	900	–	–	0.04%	205
2016 Q2	$71K	Hold	900	–	–	0.04%	197
2016 Q1	$65K	Buy	+900	New	+$68.1K	0.01%	303
2015 Q4	–	Sell	-900	Closed	-$75K	–	313
2015 Q3	$75K	Hold	900	–	–	0.01%	356
2015 Q2	$75K	Hold	900	–	–	0.01%	371
2015 Q1	$65K	Hold	900	–	–	0.01%	364
2014 Q4	$62K	Hold	900	–	–	0.01%	362
2014 Q3	$58K	Sell	900 -4,869	-84%	-$308K	﹤0.01%	385
2014 Q2	$359K	Buy	5,769 +587	+11%	+$35K	0.03%	244
2014 Q1	$305K	Buy	5,182 +422	+9%	+$23.6K	0.02%	232
2013 Q4	$243K	Buy	4,760 +470	+11%	+$23.5K	0.02%	247
2013 Q3	$216K	Buy	+4,290	New	+$225K	0.02%	236

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dreman Value Management's LLY Position: Q4 2016 in Review

Dreman Value Management sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 900 shares — an estimated $72K sold.

Dreman Value Management first reported a position in LLY in Q3 2013 and held it in 12 quarters. The position peaked at $359K in Q2 2014. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

Dreman Value Management reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
Dreman Value Management sold 900 Eli Lilly shares in Q4 2016, an estimated $72K.
Dreman Value Management first reported a position in Eli Lilly in Q3 2013 and held it in 12 quarters.
Dreman Value Management's Eli Lilly position peaked at $359K in Q2 2014.
1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Dreman Value Management's 13F filing for Q4 2016, filed 14 Feb 2017.